Join A Cure in Sight and Lisa Durbin, spouse and caregiver to Mike Durbin, an ocular melanoma patient in the metastatic community. The role of caregiver is discussed, as well as the toll this can take on a relationship, on the family as a whole. Tune in for an incredibly insightful and validating episode.
You can connect with Lisa and Mark directly to discuss their alternative approaches to metastatic management and glean from their hopeful story here: https://www.facebook.com/ldurbin1
ANNOUNCEMENTS:
5K SITES ARE OPEN FOR REGISTRATION NEAR YOU!
May 20, Raleigh, NC
https://bit.ly/3KnyTwp
May 21, Washington DC
https://bit.ly/3ZotGIZ
June 10, Minneapolis, MN
https://bit.ly/3o5Mwr2
June 11, Philly, PA
https://bit.ly/3U4hsUH
July 8, Seattle, WA
https://bit.ly/3TTgvP3
July 15, Palo Alto, CA
https://bit.ly/3lRFi9D
August 6, NYC/Brooklyn/Jersey area
https://bit.ly/40KUtQH
Head to our site to register for a 5K Lookin’ for a Cure near you for the remainder of the year!!
www.lookinforacure.org
Swing for Sight April 22, 2023
REGISTER for SWING FOR SIGHT TODAY:
Subscribe to the newsletter to stay in the know
Newsletter link
Email contact@acureinsight.org for questions regarding any upcoming events!
*********
Be sure to follow us on Facebook, Twitter, Linked In, or Instagram @acureinsight, for more stories, tips, research news, and ideas to help you navigate this journey with OM!
*A Cure in Sight is a 501c3 organization. All donations made can help fund our podcast to educate patients, fund research, aid patients, and more!
Donate $10 $15 $20 today to help A Cure in Sight in their quest to find a cure.
Contribute via PAYPAL OR VENMO or reach out directly to contact@acureinsight.org
The Eye Believe Podcast is brought to you by Castle Biosciences. Castle Biosciences is a leading diagnostics company improving health through innovative tests that guide patient care. The Company aims to transform disease management by keeping people first: patients, clinicians, employees and investors.
This podcast was hosted by Danet Peterson and produced by Page Fronczek.
